IncFact
Company Profiles: Revenue, Growth, Competition

LIGAND PHARMACEUTICALS Revenue, Growth & Competitor Profile

Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Ligand Pharmaceuticals

Access the complete profile.

Ligand Pharmaceuticals Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Address3911 Sorrento Valley Boulevard
San Diego, CA 92121

www.ligand.com


Ligand Pharmaceuticals's annual revenues are $100-$500 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Scientific Research & Development Services industry.


Ligand Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Ligand Pharmaceuticals is a publicly traded company on NGM using the ticker symbol LGND. Detailed information on company financials and operating reports can be found here: NGM: LGND



Ligand Pharmaceuticals Annual Revenue and Growth Rate

Ligand Pharmaceuticals Revenue Est.
($ Million)
Growth Rate (%)# Employees
2018 Details in Premium Report
2017
2016
2015
2014
2013
2012


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Ligand Pharmaceuticals's revenues are gauged from an analysis of company filings.



Investor Activity

Ligand Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
January 25, 2016 22 100%$85 MM
Complete list of funding rounds and total amounts in the Company Report




Trademark Applications

Trademark applications show the products and services that Ligand Pharmaceuticals is developing and marketing. Ligand Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
LTP TECHNOLOGY
Pharmaceutical research and development of a process to deliver organ specific pharmaceutical preparations
03/29/2019
VDP VERNALIS DESIGN PLATFORM
drug discovery services
03/11/2019
VDP
drug discovery services
03/11/2019

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Ligand Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Ligand Pharmaceuticals is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



Market Share of Ligand Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Ligand Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
SRI INTERNATIONALMenlo Park, CA100 
COLD SPRING HARBOR LABORATORYCold Spring Harbor, NY47 
QUINTILESDurham, NC14 
OMNICARECincinnati, OH13 
SYNEOS HEALTHRaleigh, NC8 
ALEXION PHARMACEUTICALSNew Haven, CT7 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM6 
LEIDOSReston, VA6 
BECHTEL MARINE PROPULSIONWest Mifflin, PA6 




Nearby Competitors

These companies are similar in business line and location to Ligand Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ILLUMINASan Diego, CA100 
ATHEROS COMMUNICATIONSSan Diego, CA40 
SANTARUSSan Diego, CA13 
NEUROCRINE BIOSCIENCESSan Diego, CA11 
SAMUMEDSan Diego, CA10 
LIGAND PHARMACEUTICALSSan Diego, CA9 




Future Competition: Ligand Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Ligand Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Ligand Pharmaceuticals Competitors